Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Netherlands Heart Journal
Published in: Netherlands Heart Journal 4/2015

Open Access 01-04-2015 | Editorial Comment

There is only one big risk you should avoid at all costs, and that is the risk of doing nothing

Author: J. Daemen

Published in: Netherlands Heart Journal | Issue 4/2015

Login to get access

Excerpt

This issue of the Netherland Heart Journal presents the meta-analysis of Rasoul et al. [1] in which they question the optimal treatment strategy for patients presenting with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, an extremely relevant question to those who are regularly confronted with STEMI patients. The study queues up in line with a large number of studies and meta-analyses on the same topic published in the past 10 years. Unfortunately, their results are conflicting, which is not surprising given the differential study designs and potpourri of confounders in the research question. …
Literature
1.
Rasoul S, van Ommen V, Vainer J, et al. Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis. Neth Heart J. 2015;23. doi: 10.1007/s12471-015-0673-x.
2.
Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart. 2005;91(12):1541–4.CrossRefPubMedCentralPubMed
3.
Rosner GF, Kirtane AJ, Genereux P, et al. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circulation. 2012;125(21):2613–20.CrossRefPubMed
4.
Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv. 2009;2(1):17–25.CrossRefPubMed
5.
Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008;118(11):1146–54.CrossRefPubMed
6.
Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213–24.CrossRefPubMed
7.
da Costa BR, Juni P. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls. Eur Heart J. 2014;35(47):3336–45.CrossRefPubMed
8.
Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369(12):1115–23.CrossRefPubMed
9.
Gu YL, van der Horst IC, Douglas YL, Svilaas T, Mariani MA, Zijlstra F. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J. 2010;18(7–8):348–54.CrossRefPubMedCentralPubMed
Metadata
Title
There is only one big risk you should avoid at all costs, and that is the risk of doing nothing
Author
J. Daemen
Publication date
01-04-2015
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 4/2015
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-015-0675-8

Other articles of this Issue 4/2015

Netherlands Heart Journal 4/2015 Go to the issue

Original article

Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study

Rhythm Puzzle - Question

What is the Origin of the Ectopic Beat?

Editor’s Comment

CVON: a laudable strategy waiting for societal impact

Review Article

Managing patients with advisory defibrillator leads: what can we learn from published data?

Original Article - Design Study Article

Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging

Rhythm Puzzle - Answer

What is the origin of the ectopic beat?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits